On May 8, 2023, Shanghai UniXell Biotechnology Co., Ltd. (hereinafter referred to as "UniXell ") announced that Ms. Emily Chen was appointed as the company's chief operating officer (COO). Ms. Emily Chen will lead the overall operation of the company, be fully responsible for the construction of the clinical team and related business, assist the company's strategic business development, and accelerate the registration application and clinical trial process of UniXell's Parkinson's disease pipeline. Ms. Emily Chen will report directly to the Board of Directors of UniXell.